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Abstract: Diabetes affects extracellular matrix (ECM) metabolism, contributing to delayed wound
healing and lower limb amputation. Application of light (photobiomodulation, PBM) has been shown
to improve wound healing. This study aimed to evaluate the influence of PBM on cell adhesion
molecules (CAMs) in diabetic wound healing. Isolated human skin fibroblasts were grouped into a
diabetic wounded model. A diode laser at 660 nm with a fluence of 5 J/cm2 was used for irradiation
and cells were analysed 48 h post-irradiation. Controls consisted of sham-irradiated (0 J/cm2) cells.
Real-time reverse transcription (RT) quantitative polymerase chain reaction (qPCR) was used to
determine the expression of CAM-related genes. Ten genes were up-regulated in diabetic wounded
cells, while 25 genes were down-regulated. Genes were related to transmembrane molecules, cell–cell
adhesion, and cell–matrix adhesion, and also included genes related to other CAM molecules. PBM
at 660 nm modulated gene expression of various CAMs contributing to the increased healing seen in
clinical practice. There is a need for new therapies to improve diabetic wound healing. The application
of PBM alongside other clinical therapies may be very beneficial in treatment.
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1. Introduction
1.1. Wound Healing and Diabetes
Wound healing is a physiological event critical to the continuity of life. It constitutes a complicated
process whereby tissue injury results in a healing process involving various cell types including
fibroblasts, cytokines, extracellular matrix (ECM) proteins, and certain growth factors to bring
about tissue repair and restore integrity. Wound healing is as a result of four highly coordinated
phases, namely haemostasis, inflammation, cell proliferation and remodelling. Fibroblasts are vital
components of the ECM. They produce collagen that maintains cellular integrity, as well as activate
the production of growth factors and other secretions to enhance wound repair. In conditions such
as diabetes mellitus (DM), wounds are often stuck in the inflammatory phase, and there is increased
inflammation and ECM degradation at the wound site due to decreased collagen production and
increased proteolytic activity. There is also decreased production of growth factors and cytokines,
with cells becoming unresponsive to growth factors, as well as reduced cell proliferation, and changes
in gene expression [1–5]. The pathogenesis of DM is not properly comprehended; however, previous
studies have shown that the production of several ECM factors are altered by hyperglycaemia.
Culture conditions modulated expression of ECM proteins including cell adhesion molecules (CAMs)
in vitro [6–8]. These pathological changes contribute to the development of chronic wounds, one of
the most common complications associated with the disease which affects around 15% of patients [9].
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Chronic foot ulcers often necessitate amputation, resulting in a decrease in the quality of life, as well
as creating a socio-economic burden on the country and patients. Various therapeutic interventions,
including photobiomodulation (PBM), have been used to improve wound healing in cases of diabetes
and other stressed conditions.
1.2. Cell Adhesion Molecules
CAMs are binding proteins located on the surface of the cell and bind to other cells or the ECM.
CAMs constitutes four superfamilies, namely the immunoglobulin superfamily (IgCAMs), integrins,
selectins and cadherins, and play a vital role during wound healing. It is fundamental to regulate CAMs
during tissue repair to enable cell migration, protein production and proliferation [10–12]. Cadherins
and integrins are primarily cell surface transmembrane receptors. Their main function is to stimulate
cell-cell and cell-matrix adhesion. They are also responsible for cell proliferation, differentiation,
migration, survival and gene expression [13]. Integrins are heterodimeric transmembrane proteins that
play important roles during developmental and pathological processes, including cell proliferation,
differentiation, cell-cell attachment, adhesion and signal transduction between the cell and ECM [14].
Their adhesive nature allows them to bind to other ECM proteins such as vitronectin, fibronectin,
laminin and collagen. Expressed integrins remain inactive and bind to their ligands only when
activated. They mediate bi-directional signalling across the plasma membrane, inducing intracellular
signals and are activated in three different states, low, basal and high, allowing them to change their
expression in various receptors [15–17]. Various cell types express integrins, including fibroblasts [18].
Cadherins are calcium-independent adhesion molecules mainly involved in tissue and embryonic
cell development. Their adhesive property is dependent on the ability of their intracellular domain
to interact with cytoplasmic proteins. Cadherins are found at intercellular junctions that keep
cells together, sense changes in mechanical tension and mechanotransducers and ensures adaptive
support, and serve as a link between the ECM and the cytoskeleton to activate a large number of
molecules and pathways [19,20]. Ig-CAMs express both heterophilic and homophylic binding of
laminins, fibronectins, collagens and other cell surface proteins. They are particularly involved in
cell-cell adhesion, embryogenesis and wound healing. Furthermore, they interact with integrin’s to
enhance wound repair [21]. Selectins are up-regulated when stimulated. Fibroblasts are important
in the secretion of soluble factors and synthesizing the ECM to regulate neovascularization [22,23].
Experiments on selectins have been shown to improve neovascularization, stromal cell derived factor
(SDF)-α1 homing and wound healing [22]. E and P selectins also regulate inflammatory cell infiltration
and improves wound healing.
1.3. Photobiomodulation (PBM)
The application of PBM is a non-invasive therapeutic process for wound healing involving
low energy power lasers or light emitting diodes (LEDs). Through several chemical, cellular and
biological processes, PBM is capable of relieving pain and inflammation [24,25], as well as enhancing
wound healing. PBM has been known for its biostimulatory effect in wound healing through various
wavelengths, typically in the visible and near-infrared (NIR), and at low energy densities (fluencies).
However, its mechanism of action is not fully understood. Currently, what is known, and the most
accepted theory is that photons are absorbed by mitochondrial cytochrome C oxidase (Cox) which
results in increased electron transfer, resulting in increased intracellular reactive oxygen species (ROS)
and increased production of adenosine triphosphate (ATP). Nitric oxide (NO) is also photodissociated
from Cox, which when bound to it inhibits Cox activity [26]. This brings about changes in cellular redox
potential and pH levels, potassium and calcium ions, and cyclic adenosine monophosphate (cAMP)
levels (derivative of ATP), which all play an important role in signal transduction, and induce several
transcription factors [27]. These changes will bring about changes and stimulate cellular proliferation
and migration, increased production and release of growth factors and cytokines, as well stimulation
of ECM accumulation. Studies have shown that PBM modulates fibroblast cell proliferation and
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gene expression in wounded models at different wavelengths and fluences [28–32]. Investigations
on diabetic wound healing involving humans, rats and other animal models has also shown positive
effects [33–41]. Discovering and understanding the functions of CAMs in wound healing will allow
for identification of mechanisms in medical conditions such as in chronic wounds [16]. Therefore, this
study aimed to evaluate the influence of PBM on CAMs in diabetic wound healing.
2. Materials and Methods
2.1. Cell Isolation and Culure
Tissue was donated and collected from a consenting adult donor undergoing abdominoplasty
(Linksfield, Sandringham, Johannesburg, South Africa). The isolation of cells from such tissue received
ethical approval from the University of Johannesburg, Faculty Academic Ethics Committee (Clearance
Reference Number: AEC05/01-2011). Briefly, adipose tissue was separated from the dermis with a
sterile scalpel and the skin cut into 2–3 cm2 pieces. These smaller pieces of tissue were then incubated
overnight at 37 ◦C, 5% CO2 in 10 mL of 0.25% Trypsin-1 mM Ethylenediaminetetraacetic acid (EDTA,
ThermoFisher Scientific, Fairland, Johannesburg, South Africa, 25200-056). Trypsin was neutralised
with an equal volume of media (Minimum Essential Medium, MEM, Sigma-Aldrich, Aston Manor,
Johannesburg, South Africa, M7278) containing 10% Foetal Bovine Serum (FBS, Sigma-Aldrich, F9665).
The dermis was then pulled away from and separated from the epidermis using a forcep. The dermis
was then digested with 15 mL of 10 mg/mL collagenase-1 in Hanks Balanced Salt Solution (HBSS)
with calcium (Ca2+) and magnesium (Mg2+) ions (Sigma-Aldrich, 55037C) and incubated for 40 min at
37 ◦C at 100 rpm (Labcon, Krugersdorp, Johannesburg, South Africa, shaker incubator, 3081u). Tissue
was mechanically dissociated by pipetting several times (25 mL to 10 mL and then 5 mL disposable
pipettes). Isolated cells were re-suspended in 20 mL complete MEM and cultured in T75 tissue culture
flasks incubated overnight at 37 ◦C, 5% CO2. The media was selective for the growth of fibroblasts.
Isolated cells were cultured according to standard culture methods [42]. Briefly, cells were
incubated at 37 ◦C, 5% CO2 in MEM supplemented with 10% FBS, 1 mM sodium pyruvate
(ThermoFisher Scientific, Fairland, Johannesburg, South Africa, 11360-039), 2 mM L-glutamine
(ThermoFisher Scientific, Gibco®, 25030-024), 0.1 mM non-essential amino acids (NEAA, ThermoFisher
Scientific, Gibco®, 11140-035), 1% Penicillin-Streptomycin (ThermoFisher Scientific, Gibco®, 15140-122)
and 0.2% Amphotericin-B (ThermoFisher Scientific, Gibco®, 15290-020) in T75/T175 culture flasks.
Cells were detached with 1 mL/25 cm2 TrypLE™ Express (ThermoFisher Scientific, Gibco®, 12604-021).
Cells between passage numbers 7 and 12 were used in experiments. A diabetic wounded model
was achieved by continuously growing cells under hyperglycemic conditions; cells were cultured in
complete media (basal glucose concentration of 5.6 mMol/L) containing an additional 17 mMol/L
D-glucose [43,44]. Mimicking a diabetic condition using high glucose concentrations of 20–40 mM/L is
not uncommon in inducing cellular changes in different cell types in vitro [45–48]. For experiments,
6 × 105 cells in 3 mL complete media were seeded into 3.4 cm diameter tissue culture plates and
cells allowed to adhere during overnight incubation. The following morning cells were rinsed with
warm HBSS and 1 mL fresh media added to cultures. A wound was simulated in vitro via the scratch
assay [49–51] under the same conditions, whereby a sterile 1 mL disposable pipette was used to scrape
the confluent monolayer in a straight line, creating a cell-free zone in the center with cells either side of
the ‘wound’ [44].
2.2. Laser Irradiation
Following the creation of a central scratch, cells were incubated for 30 min. A continuous wave
diode laser emitting at a wavelength of 660 nm (Fremont, CA, USA, RGBlase, TECIRL-100G-650SMA)
was used to irradiate cells (Table 1) in 3.4 cm diameter tissue culture dishes. This wavelength and
laser parameters were chosen as they have previously shown stimulatory effects on WS1 cells [52,53].
Cells were irradiated via fibber optics in the dark from the top and at a distance that created the same
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spot size as the culture dish (7 cm). The temperature of the culture media was recorded every 2 min
during irradiation to eliminate any effects produced by heat [28]. The duration of laser irradiation was
determined by the output power (and hence output power density). Sham-irradiated (0 J/cm2) cells
were used as controls.
Table 1. Laser parameters.
Parameters
Wavelength 660 nm
Output power 92.8 mW
Spot size 9.1 cm2
Output power density 10.22 mW/cm2
Fluence 5 J/cm2
Duration of irradiation 8 min 9 s
2.3. PCR Array
Forty-eight hours post-irradiation, cells were detached and total RNA isolated using the RNeasy
Mini Kit (Whitehead Scientific, Cape Town, South Africa, Qiagen, Hilden, Germany, 74104) and
QIAshredder homogenisers performed on the QIAcube (Qiagen) as previously described [53].
RNA was quantified on the Qubit™ fluorometer (Invitrogen) using the Quant-iT™ RNA Assay
kit (ThermoFisher Scientific, Invitrogen, Q32852), and purity determined spectrophotometrically at
A260 nm/A280 nm. cDNA was reverse transcribed from 1 µg total RNA by means of the Quanti-Tect
Reverse Transcription Kit (Whitehead Scientific, Qiagen, 205311). Briefly, following treatment with
DNase, sample was incubated at 42 ◦C for 5 min. RT master mix was added and samples incubated
at 42 ◦C for 15 min followed by 3 min incubation at 95 ◦C. cDNA was stored at −20 ◦C until ready
for qPCR.
The Human Extracellular Matrix and Adhesion Molecules RT2 Profiler™ PCR Array (Whitehead
Scientific, SABiosciences, Frederick, MD, USA, PAHS-013Z) was used to profile the expression of 84
genes important for cell-cell and cell-matrix interactions as previously described [28]. Of these 84
genes, 64 were CAMs (Table 2). Briefly, 111 µL cDNA was added to the master mix (containing
ROX as a reference dye and SYBR green) and 25 µL was added to each well. Real-time qPCR
was performed on the Stratagene MX3000p (Diagnostech, Dainfern Valley, Johannesburg, South
Africa, Agilent Technologies, Waldbronn, Germany) using the following cycles: 1 cycle at 95 ◦C for
10 min; 40 cycles at 95 ◦C for 15 s and 60 ◦C for 1 min. A dissociation curve was performed at
the end of the program to ensure the amplification of a single product (single peak at temperatures
greater than 80 ◦C had to be obtained). Results were normalised against an average of all five
housekeeping/reference genes and analysed on an excel based spreadsheet (Available from the
SABiosciences website, http://www.sabiosciences.com). Threshold cycle (Ct) values greater than 35
were considered negative. Normalised expression levels from irradiated cells were calculated relative
to non-irradiated control cells according to the 2−∆∆Ct method and the genes were considered up- or
down-regulated if the difference was >1 or <1, respectively.
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Table 2. Functional CAM gene grouping.
Pathway Gene
Transmembrane Molecules
CD44, CDH1, HAS1, ICAM1, ITGA1, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7,
ITGA8, ITGAL, ITGAM, ITGAV, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, MMP14, MMP15,
MMP16, NCAM1, PECAM1, SELE, SELL, SELP, SGCE, SPG7, VCAM1
Cell-Cell Adhesion CD44, CDH1, COL6A2, COL11A1, COL14A1, CTNND1, ICAM1, ITGA8, VCAM1
Cell-Matrix Adhesion ADAMTS13, CD44, ITGA1, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGA7, ITGA8,ITGAL, ITGAM, ITGAV, ITGB1, ITGB2, ITGB3, ITGB4, ITGB5, SGCE, SPP1, THBS3
Other Adhesion Molecules
CLEC3B, CNTN1, COL5A1, COL6A1, COL7A1, COL8A1, COL12A1, COL15A1,
COL16A1, CTGF, CTNNA1, CTNNB1, CTNND2, FN1, KAL1, LAMA1, LAMA2, LAMA3,
LAMB1, LAMB3, LAMC1, THBS1, THBS2, TNC, VCAN, VTN
Housekeeping genes B2M, HPRT1, RPL13A, GAPDH, ACTB
2.4. Statistical Analysis
Experiments were repeated three times (n = 3). Results were normalised against an average
of all five housekeeping/reference genes. The student t-test was performed by the SABiosciences
Excel-based Data Analysis Template and reported as significant if p <0.05.
3. Results
Forty-eight hours post-irradiation at a wavelength of 660 nm with 5 J/cm2, 64 genes related
to CAMs was determined by real-time RT-qPCR in an in vitro diabetic wounded model (Table 3).
Of the 64 genes, 25 were significantly down-regulated (Figure 1), while ten were significantly
up-regulated (Figure 2). Eleven genes coding for transmembrane molecules were down-regulated
(CD44, ITGA2, ITGA3, ITGA5, ITGA6, ITGAV, ITGB1, ITGB3, MMP14, MMP16, and SPG7), while five
were up-regulated (CDH1, ITGA8, ITGAL, ITGB4, SELL, and VCAM1). Three genes coding for
cell-cell adhesion molecules were down-regulated (CD44, COL6A2, and CTNND1), while five were
up-regulated (CDH1, COL11A1, COL14A1, ITGA8 and VCAM1). Nine genes coding for cell-matrix
molecules were down-regulated (CD44, ITGA2, ITGA3, ITGA5, ITGA6, ITGAV, ITGB1, ITGB3,
and SSP1), and three were up-regulated (ITGA8, ITGAL, and ITGB4). Genes related to other CAMs were
also regulated by PBM, and 11 genes were down-regulated (COL5A1, COL6A1, COL7A1, COL12A1,
COL16A1, FN1, KAL1, LAMA1, LAMB3, LAMC1 and THBS1) and two were up-regulated (CNTN1
and LAMA3).
Figure 1. Significant down-regulation (fold difference <1) of genes related to CAMs in diabetic
wounded cells irradiated with 660 nm at 5 J/cm2.
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Table 3. Gene expression profile of CAMs in diabetic wounded human skin fibroblast cells irradiated at 660 nm with 5 J/cm2. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001.
Gene Symbol Description Gene ID Fold Difference 1 p-Value Gene Function [54]
ADAMTS13 ADAM metallopeptidase withthrombospondin type 1 motif, 13 11093 0.91 0.589 The enzyme encoded by this gene specifically cleaves von Willebrand Factor (vWF).
CD44 CD44 molecule (Indian blood group) 960 0.53 0.049 *
The protein encoded by this gene is a cell-surface glycoprotein involved in cell-cell
interactions, cell adhesion and migration. It is a receptor for hyaluronic acid (HA) and can
also interact with other ligands, such as osteopontin, collagens, and matrix
metalloproteinases (MMPs).
CDH1 Cadherin 1, type 1, E-cadherin 999 2.12 0.050 * This gene encodes a classical cadherin of the cadherin superfamily, and is a cell-celladhesion protein.
CTNNA1 Catenin (cadherin-associated protein),alpha 1, 102 kDa 1495 0.83 0.340
This gene encodes a member of the catenin family of proteins that play an important role in
cell adhesion process by connecting cadherins located on the plasma membrane to the actin
filaments inside the cell.
CTNNB1 Catenin (cadherin-associated protein),beta 1, 88 kDa 1499 0.64 0.084
The protein encoded by this gene is part of a complex of proteins that constitute adherens
junctions, which are necessary for the creation and maintenance of epithelial cell layers by
regulating cell growth and adhesion between cells. They also anchor the actin cytoskeleton
and may be responsible for transmitting the contact inhibition signal that causes cells to
stop dividing once the epithelial sheet is complete.
CTNND1 Catenin (cadherin-associated protein),delta 1 1500 0.36 0.005 **
This gene encodes a member of the Armadillo protein family, which function in adhesion
between cells and signal transduction.
CTNND2
Catenin (cadherin-associated protein),
delta 2 (neural plakophilin-related
arm-repeat protein)
1501 2.72 0.052
This gene encodes an adhesive junction associated protein of the armadillo/beta-catenin
superfamily. The protein also promotes the disruption of E-cadherin based adherens
junction to favour cell spreading upon stimulation by hepatocyte growth factor.
CLEC3B C-type lectin domain family 3, member B 7123 1.14 0.749 This gene codes for the protein tetranectin which may be involved in the packaging ofmolecules destined for exocytosis.
CNTN1 Contactin 1 1272 2.19 0.041 *
The protein encoded by this gene is a member of the immunoglobulin superfamily. It is a
glycosyl-phosphatidylinositol (GPI)-anchored neuronal membrane protein that functions
as a cell adhesion molecule.
CTGF Connective tissue growth factor 1490 1.10 0.521
The protein encoded by this gene is a mitogen that is secreted by vascular endothelial cells.
The encoded protein plays a role in chondrocyte proliferation and differentiation, cell
adhesion in many cell types, and is related to platelet-derived growth factor.
COL5A1 Collagen, type V, alpha 1 1289 0.56 0.036 *
This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Type V
collagen is found in tissues containing type I collagen and appears to regulate the assembly
of heterotypic fibbers composed of both type I and type V collagen. This gene product is
closely related to type XI collagen and it is possible that the collagen chains of types V and
XI constitute a single collagen type with tissue-specific chain combinations.
COL6A1 Collagen, type VI, alpha 1 1291 0.64 0.015 *
The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI),
and alpha3(VI) chains. The protein encoded by this gene is the alpha 1 subunit of type VI
collagen (alpha1(VI) chain). Collagen VI is a major structural component of microfibrils.
COL6A2 Collagen, type VI, alpha 2 1292 0.58 0.014 *
The protein encoded by this gene is the alpha 2 subunit of type VI collagen (alpha2(VI)
chain). Type VI collagen is a beaded filament collagen found in most connective tissues.
The product of this gene contains several domains similar to von Willebrand Factor type A
domains. These domains have been shown to bind ECM proteins, which explains the
importance of this collagen in organizing matrix components.
COL7A1 Collagen, type VII, alpha 1 1294 0.36 0.017 *
This gene encodes the alpha 1 subunit of type VII collagen. Type VII collagen fibril,
composed of three identical alpha collagen chains, is restricted to the basement zone and
functions as an anchoring fibril between the external epithelia and the underlying stroma.
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Table 3. Cont.
Gene Symbol Description Gene ID Fold Difference 1 p-Value Gene Function [54]
COL8A1 Collagen, type VIII, alpha 1 1295 0.71 0.271
This gene encodes the alpha 1 subunit (one of two alpha chains) of type VIII collagen. The gene
product is a short chain collagen and a major component of the basement membrane of the
corneal endothelium.
COL11A1 Collagen, type XI, alpha 1 1301 3.68 0.002 ** This gene encodes the alpha 1 subunit (one of two chains) of type XI collagen, a minorfibrillar collagen.
COL12A1 Collagen, type XII, alpha 1 1303 0.37 0.003 **
This gene encodes the alpha 1 subunit of type XII collagen, a member of the FACIT
(fibril-associated collagens with interrupted triple helices) collagen family. Type XII collagen is
a homotrimer found in association with type I collagen, an association that is thought to
modify the interactions between collagen I fibrils and the surrounding matrix.
COL14A1 Collagen, type XIV, alpha 1 7373 1.24 0.023 *
This gene encodes the alpha 1 subunit of type XIV collagen, a member of the FACIT collagen
family. Type XIV collagen interacts with the fibril surface and is involved in the regulation
of fibrillogenesis.
COL15A1 Collagen, type XV, alpha 1 1306 0.67 0.082
This gene encodes the alpha 1 subunit of type XV collagen, a member of the FACIT collagen
family. Type XV collagen has a wide tissue distribution but the strongest expression is
localized to basement membrane zones so it may function to adhere basement membranes to
underlying connective tissue stroma.
COL16A1 Collagen, type XVI, alpha 1 1307 0.61 0.001 **
This gene encodes the alpha 1 subunit of type XVI collagen, a member of the FACIT collagen
family. Members of this collagen family are found in association with fibril-forming collagens
such as type I and II, and serve to maintain the integrity of the ECM.
FN1 Fibronectin 1 2335 0.58 0.008 **
This gene encodes fibronectin, a glycoprotein present in a dimeric or multimeric form at the
cell surface and in ECM. The encoded preproprotein is proteolytically processed to generate
the mature protein. Fibronectin is involved in cell adhesion and migration processes including
wound healing.
HAS1 Hyaluronan synthase 1 3036 0.87 0.544
Hyaluronan or hyaluronic acid (HA) is a polysaccharide and is a constituent of the ECM. It
serves a variety of functions, including space filling, lubrication of joints, and provision of a
matrix through which cells can migrate. HA is actively produced during wound healing and
tissue repair to provide a framework for ingrowth of blood vessels and fibroblasts. HA is
synthesized by membrane-bound synthase at the inner surface of the plasma membrane.
ICAM1 Intercellular adhesion molecule 1 3383 0.97 0.843 This gene encodes a cell surface glycoprotein which is typically expressed on endothelial cellsand cells of the immune system. It binds to integrins of type CD11a/CD18, or CD11b/CD18.
ITGA1 Integrin, alpha 1 3672 0.97 0.721
This gene encodes the alpha 1 subunit of integrin receptors. This protein heterodimerizes with
the beta 1 subunit to form a cell-surface receptor for collagen and laminin. The heterodimeric
receptor is involved in cell-cell adhesion and may play a role in inflammation and fibrosis.
The alpha 1 subunit contains an inserted (I) von Willebrand factor type I domain which is
thought to be involved in collagen binding.
ITGA2 Integrin, alpha 2 (CD49B, alpha 2subunit of VLA-2 receptor) 3673 0.52 0.015 *
This gene encodes the alpha 2 subunit of a transmembrane receptor for collagens and related
proteins. The encoded protein forms a heterodimer with a beta subunit and mediates the
adhesion of platelets and other cell types to the ECM.
ITGA3 Integrin, alpha 3 (antigen CD49C, alpha3 subunit of VLA-3 receptor) 3675 0.50 0.010 **
This gene encodes the alpha 3 subunit of integrin. Integrins are heterodimeric integral
membrane proteins that function in cell surface adhesion, cytoskeletal rearrangement and cell
signalling. This subunit joins with a beta 1 subunit to form an integrin that interacts with ECM
proteins, including members of the laminin family.
ITGA4 Integrin, alpha 4 (antigen CD49D, alpha4 subunit of VLA-4 receptor) 3676 0.86 0.459
This gene encodes for the alpha 4 subunit of the integrin alpha chain family. This subunit
associates with a beta 1 or beta 7 subunit to form an integrin that may play a role in cell
motility and migration.
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Table 3. Cont.
Gene Symbol Description Gene ID Fold Difference 1 p-Value Gene Function [54]
ITGA5 Integrin, alpha 5 (fibronectin receptor,alpha polypeptide) 3678 0.54 0.004 **
This gene encodes for the alpha 5 subunit of the integrin alpha chain family. This subunit
associates with the beta 1 subunit to form a fibronectin receptor.
ITGA6 Integrin, alpha 6 3655 0.76 0.012 *
This gene encodes for the alpha 6 subunit of the integrin alpha chain family. This subunit may
associate with a beta 1 or beta 4 subunit to form an integrin that interacts with ECM proteins
including members of the laminin family.
ITGA7 Integrin, alpha 7 3679 1.11 0.513
This gene encodes for the alpha 7 subunit of the integrin alpha chain family. This protein
functions as a receptor for the basement membrane protein laminin-1. It is mainly expressed in
skeletal and cardiac muscles and may be involved in differentiation and migration processes
during myogenesis.
ITGA8 Integrin, alpha 8 8516 2.75 0.050 *
This gene encodes for the alpha 8 subunit of the heterodimeric integrin alpha8beta1 protein.
The encoded protein is a single-pass type 1 membrane protein. This gene regulates the
recruitment of mesenchymal cells into epithelial structures, mediates cell-cell interactions, and
regulates neurite outgrowth of sensory and motor neurons. The integrin alpha8beta1 protein
plays an important role in wound-healing and organogenesis.
ITGAL
Integrin, alpha L (antigen CD11A (p180),
lymphocyte function-associated antigen
1; alpha polypeptide)
3683 1.89 0.003 **
This gene encodes the integrin alpha L chain. This I-domain containing alpha integrin combines
with the beta 2 chain (ITGB2) to form the integrin lymphocyte function-associated antigen-1
(LFA-1). LFA-1 plays a central role in leukocyte intercellular adhesion through interactions with
its ligands, ICAMs 1-3, and also functions in lymphocyte costimulatory signalling.
ITGAM Integrin, alpha M (complementcomponent 3 receptor 3 subunit) 3684 1.77 0.065
This gene encodes the integrin alpha M chain. This I-domain containing alpha integrin combines
with the beta 2 chain (ITGB2) to form a leukocyte-specific integrin known as macrophage
receptor 1 (‘Mac-1’), or inactivated-C3b (iC3b) receptor 3 (‘CR3’). The alpha M beta 2 integrin is
important in the adherence of neutrophils and monocytes to stimulated endothelium, and also in
the phagocytosis of complement coated particles.
ITGAV Integrin, alpha V (vitronectin receptor,alpha polypeptide, antigen CD51) 3685 0.50 0.002 **
The product of this gene belongs to the integrin alpha chain family. This subunit associates with
beta 1, beta 3, beta 5, beta 6 and beta 8 subunits. The heterodimer consisting of alpha V and beta
3 subunits is also known as the vitronectin receptor. This integrin may regulate angiogenesis.
ITGB1
Integrin, beta 1 (fibronectin receptor, beta
polypeptide, antigen CD29 includes
MDF2, MSK12)
3688 0.53 0.005 **
The product of this gene belongs to the integrin beta chain family; integrin beta chains combine
with multiple different alpha chains to form different integrin heterodimers. The ITGB1 protein
product is the integrin beta chain beta 1. Integrin family members are noncovalently associated
transmembrane glycoprotein receptors involved in cell adhesion and recognition in a variety of
processes including embryogenesis, hemostasis, tissue repair, and immune response.
ITGB2 Integrin, beta 2 (complement component3 receptor 3 and 4 subunit) 3689 1.58 0.083
The ITGB2 protein product is the integrin beta chain beta 2. The encoded protein plays an
important role in immune response.
ITGB3 Integrin, beta 3 (platelet glycoprotein IIIa,antigen CD61) 3690 0.58 0.006 **
The ITGB3 protein product is the integrin beta chain beta 3. Integrin beta 3 is found along with
the alpha IIb chain in platelets.
ITGB4 Integrin, beta 4 3691 1.87 0.041 * This gene encodes the integrin beta 4 subunit, a receptor for the laminins.
ITGB5 Integrin, beta 5 3693 0.97 0.879 This gene encodes the integrin subunit beta 5, and is involved in adhesion to vitronectin.
KAL1 Kallmann syndrome 1 sequence 3730 0.41 0.001 *** Also known as the ANOS1 gene. The protein encoded for by this gene is a cell surface protein,which is N-glycosylated and may have anti-protease activity.
LAMA1 Laminin, alpha 1 284217 0.60 0.014 *
This gene encodes one of the alpha 1 subunits of laminin. Laminins are a family of ECM
glycoproteins that have a heterotrimeric structure consisting of an alpha, beta and gamma chain
which are bound to each other by disulphide bonds into a cross-shaped molecule. These proteins
make up a major component of the basement membrane and have been implicated in a variety of
biological processes including cell adhesion, differentiation, migration, and signalling.
LAMA2 Laminin, alpha 2 3908 1.17 0.396 This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin)and laminin 4 (s-merosin).
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Table 3. Cont.
Gene Symbol Description Gene ID Fold Difference 1 p-Value Gene Function [54]
LAMA3 Laminin, alpha 3 3909 2.25 0.031 *
This gene encodes the alpha 3 chain of laminins. Laminins are essential for formation and
function of the basement membrane. This gene is responsive to several epithelial-mesenchymal
regulators including keratinocyte growth factor, epidermal growth factor and insulin-like
growth factor.
LAMB1 Laminin, beta 1 3912 0.95 0.609 This gene encodes the beta chain isoform laminin, beta 1.
LAMB3 Laminin, beta 3 3914 0.61 0.010 ** The product encoded by this gene is a beta subunit laminin, which together with an alpha and agamma subunit, forms laminin-5
LAMC1 Laminin, gamma 1 (formerly LAMB2) 3915 0.54 0.008 **
This gene encodes the gamma chain isoform laminin, gamma 1. Embryos of transgenic mice in
which both alleles of the gamma 1 chain gene were inactivated by homologous recombination,
lacked basement membranes, indicating that laminin, gamma 1 chain is necessary for laminin
heterotrimer assembly.
MMP14 Matrix metallopeptidase 14(membrane-inserted) 4323 0.44 0.016 *
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of ECM in
normal physiological processes, such as tissue remodelling. The protein encoded by this gene is
a member of the membrane-type MMP (MT-MMP) subfamily; each member of this subfamily
contains a potential transmembrane domain suggesting that these proteins are expressed at the
cell surface rather than secreted.
MMP15 Matrix metallopeptidase 15(membrane-inserted) 4324 1.24 0.157
This gene encodes a member of the peptidase M10 family and membrane-type subfamily
of MMPs.
MMP16 Matrix metallopeptidase 16(membrane-inserted) 4325 0.44 0.003 **
Most MMP’s are secreted as inactive pro-proteins which are activated when cleaved by
extracellular proteinases. The protein encoded by this gene is a member of the MT-MMP
subfamily and activates MMP2 by cleavage.
NCAM1 Neural cell adhesion molecule 1 4684 0.97 0.811
This gene encodes a cell adhesion protein which is a member of the immunoglobulin
superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix
interactions during development and differentiation. The encoded protein has been shown to be
involved in development of the nervous system, and for cells involved in the expansion of T cells
and dendritic cells which play an important role in immune surveillance.
PECAM1 Platelet/endothelial cell adhesionmolecule 5175 3.66 0.213
The protein encoded by this gene is found on the surface of platelets, monocytes, neutrophils,
and some types of T-cells, and makes up a large portion of endothelial cell intercellular junctions.
The encoded protein is a member of the immunoglobulin superfamily and is likely involved in
leukocyte migration, angiogenesis, and integrin activation.
SELE Selectin E 6401 1.50 0.078
The protein encoded by this gene is part of the selectin family of cell adhesion molecules, and is
found in cytokine-stimulated endothelial cells and is thought to be responsible for the
accumulation of blood leukocytes at sites of inflammation by mediating the adhesion of cells to
the vascular lining.
SELL Selectin L 6402 2.36 0.013 * This gene encodes a cell surface adhesion molecule that belongs to a family ofadhesion/homing receptors.
SELP Selectin P (granule membrane protein140 kDa, antigen CD62) 6403 1.90 0.249
This protein redistributes to the plasma membrane during platelet activation and degranulation
and mediates the interaction of activated endothelial cells or platelets with leukocytes.
SGCE Sarcoglycan, epsilon 8910 0.93 0.657
This gene encodes the epsilon member of the sarcoglycan family. Sarcoglycans are
transmembrane proteins that are components of the dystrophin-glycoprotein complex, which
link the actin cytoskeleton to the ECM.
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Table 3. Cont.
Gene Symbol Description Gene ID Fold Difference 1 p-Value Gene Function [54]
SPG7 Spastic paraplegia 7 (pure andcomplicated autosomal recessive) 6687 0.48 0.005 **
This gene encodes a mitochondrial metalloprotease protein that is a member of the AAA family.
Members of this protein family share an ATPase domain and have roles in diverse cellular
processes including membrane trafficking, intracellular motility, organelle biogenesis, protein
folding, and proteolysis.
SPP1 Secreted phosphoprotein 1 6696 0.58 0.009 **
The protein encoded by this gene is involved in the attachment of osteoclasts to the mineralized
bone matrix. This protein is also a cytokine that upregulates expression of interferon-gamma and
interleukin-12.
THBS1 Thrombospondin 1 7057 0.35 0.001 ***
The protein encoded by this gene is a subunit of a disulphide-linked homotrimeric protein, and
belongs to the thrombospondin family. This protein is an adhesive glycoprotein that mediates
cell-to-cell and cell-to-matrix interactions. This protein can bind to fibrinogen, fibronectin,
laminin, type V collagen and integrins alpha-V/beta-1.
THBS2 Thrombospondin 2 7058 0.81 0.088 The protein encoded by this gene belongs to the thrombo-spondin family.
THBS3 Thrombospondin 3 7059 1.03 0.794 The protein encoded by this gene belongs to the thrombo-spondin family.
TNC Tenascin C 3371 1.18 0.492 This gene encodes for an ECM protein.
VCAM1 Vascular cell adhesion molecule 1 7412 1.79 0.002 **
This gene is a member of the Ig superfamily and encodes a cell surface sialoglycoprotein
expressed by cytokine-activated endothelium. This type I membrane protein mediates
leukocyte-endothelial cell adhesion and signal transduction.
VCAN Versican 1462 0.96 0.775
This gene is a member of the aggrecan/versican proteoglycan family. The protein encoded is a
large chondroitin sulphate proteoglycan and is a major component of the ECM. This protein is
involved in cell adhesion, proliferation, migration and angiogenesis and plays a central role in
tissue morphogenesis and maintenance.
VTN Vitronectin 7448 1.20 0.240
The protein encoded by this gene is a member of the pexin family. It is found in serum and
tissues and promotes cell adhesion and spreading, inhibits the membrane-damaging effect of the
terminal cytolytic complement pathway, and binds to several serpin serine protease inhibitors.
1 A fold difference > 1 is considered as gene up-regulation, while a fold difference <1 is considered as gene down-regulation.
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Figure 2. Significant up-regulation (fold difference >1) of genes related to CAMs in diabetic wounded
cells irradiated with 660 nm at 5 J/cm2.
4. Discussion
Wound healing is a carefully controlled and balanced process aimed at reversing the loss of
structural integrity. CAMs play an important role during wound healing. Fibroblast cells play a
major role in wound healing, and carry a variety of CAMs, and a deficiency in these CAMs may lead
to delayed healing and ultimately chronic wounds [55]. Fibroblast cells produce many structural
proteins important for wound healing, such as collagen. In addition, they also produce matrix
metalloproteinases (MMPs), proteolytic enzymes which breakdown collagen. MMPs are necessary
during the early stages of wound healing as they facilitate the movement of fibroblasts to the wound site.
Later on in the wound healing stages, fibroblasts decrease their proteolytic activity and start producing
structural proteins. When phases during wound healing do not progress, chronic wounds develop.
The use of PBM both in vitro and in vivo has shown beneficial and simulative effects on wound
healing [1,56–60]. Keshri et al. [56] studied the effect of PBM at 810 nm (22.6 J/cm2), using a
pulsed (10 and 100 Hz, 50% duty cycle) diode laser, on full-thickness excision-type dermal wound
healing in hydrocortisone-induced immunosuppressed rats. Their results showed accelerated healing
through a decrease in inflammation (nuclear factor (NF)-kB, tumour necrosis factor (TNF)-α), and
enhanced wound contraction (α-(SM) smooth muscle actin), cellular proliferation, ECM deposition,
neovascularization (hypoxia inducible factor (HIF)-1α, and vascular endothelial growth factor,
VEGF), and re-epithelialization. There was an up-regulation of the protein expression of fibroblast
growth factor receptor-(FGFR)-1, fibronectin, heat shock protein (HSP)-90 and TGF-β2. Additionally,
irradiation significantly increased cytochrome c oxidase (CCO, mitochondrial complex IV) activity
and cellular adenosine triphosphate (ATP) content. Ayuk et al. [1] illustrated that diabetic wounded
fibroblast cells irradiated at 660 nm with 5 J/cm2 presented with a significant increase in cell migration,
viability, proliferation, and collagen content. In a similar study, Jere et al. [57] demonstrated that
the increase observed in proliferation and migration may be due to activation of the JAK/STAT
pathway in response to the binding of epidermal growth factor (EGF) to its receptor (EGFR). Tatmatsu
Rocha et al. [58] demonstrated the effects of PBM at 904 nm in a diabetic wounded mouse model.
Irradiated diabetic wounded mice displayed intense deposition and a more organized collagen matrix,
and decreased concentration of nitrite, a marker of oxidative stress, and thiobarbituric acid (TBARS),
a marker of lipid peroxidation. They showed that PBM was able to reduce nitrosative/oxidative stress
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in diabetic mice, thus accelerating wound healing. Beckmann et al. [59] conducted a systematic review
on PBM (also referred to as low level laser therapy, or LLLT). They analysed 22 references; 8 in vitro
studies, 6 animal studies, and 8 clinical trials. In vitro and animal studies provided proof of enhanced
cellular migration, viability, and proliferation, rapid re-epithelization and reformed connective tissue,
improved microcirculation, and anti-inflammatory effects. The clinical studies showed a potential
benefit of PBM in the healing of diabetic ulcers, and stressed that better designed research trials
are necessary. Ruh et al. [60] investigated the gene expression of inflammatory or reparative factors
(interleukin-6, IL6; TNF; VEGF; and TGF) in pressure ulcers from eight patients which were irradiated
at 660 nm with 2 J/cm2. Analysis of the lesions post-irradiation showed a 50% improvement in the size
of granulation tissue, with a decrease in the gene expression in TNF-α, and an increase in VEFG and
TGF-β. They concluded that PBM may be a beneficial complementary treatment for pressure ulcers.
CAMs play a vital role in wound healing, and is important in cellular proliferation, migration
and the production of proteins [16]. During the initial phases of wound healing, fibrinogen,
fibronectin, and vitronectin are produced to establish the provisional wound matrix of the blood
clot. Other ECM proteins such as osteopontin, thrombospondins, secreted protein acidic and rich in
cysteine (SPARC), tenascins, and collagens are released, and are only briefly present [16]. This study
found a down-regulation in fibronectin-1, thrombospondin-1 (no effect on thrombospondin-2 and -3),
CD44 (a glycoprotein which interacts with osteopontin), and collagen types -V, -VI, -VII, -XII, and -XVI
in diabetic wounded fibroblast cells exposed to PBM at 660 nm with 5 J/cm2 and left to incubate for
48 h. No effect on the expression of tenascin C and vitronectin was observed. Tenascin-C holds both
adhesive and anti-adhesive properties, depending on the cellular context. Keshri et al. [56] found an
increase in the expression of fibronectin when using an 810 nm pulsed laser in an immunosuppressed
rat wounded model. In this study, there was a significant up-regulation in the expression of collagen
type -XI and -XIV. Both these collagens are involved in fibrillogenesis. Fibril formation during wound
healing is primarily carried out by collagen type I and III. Previous studies in the same cells have
shown an increase in collagen type I secretion, as well as its up-regulation in response to irradiation at
660 nm with 5 J/cm2 [1,61]. Carvalho et al. [62] and Colombo et al. [63] both found increased collagen
and improved healing in wounded rat models in response to PBM. In this study, there was a significant
down-regulation in proteases MMP14 and MMP16, as well as SPG7, which codes for a mitochondrial
metalloprotease and is necessary for intracellular motility and membrane trafficking. MMPs are
secreted as inactive pro-proteins and require cleavage for activation. They are needed during tissue
remodelling and maintaining the balance of the ECM. Often in the case of DM, MMP levels are elevated
which contributes to the non-healing of chronic wounds [64]. Gharagozlian et al. [64] showed that
PBM at 810 nm (1 or 3 J/cm2) reduced the gene expression of MMP3, MMP9, and MMP13 in Achilles
tendons of rats. Casalechi et al. [65] showed that a wavelength of 780 nm (7.5 J/cm2) modulated gene
expression of MMP1 and MMP13 in Wistar rats.
Integrins form a cell-surface receptor for collagen and laminin, and are the main mediators of cell
attachment to the ECM [66]. This super-family consists of 24 varieties, all formed by one of 18 alpha
subunits and one of 8 beta subunits. Extracellular ligand binding (such as fibronectin and laminin)
promotes intracellular signalling. Integrins play a vital role in cell migration, and also allow cells
to interact with the wound ECM. Several integrins are functionally stimulated or their expression is
up-regulated in response to their contact with ECM molecules [16]. In this study, there was a significant
down-regulation in a number of integrin alpha subunits: A2, which is expressed in the initial stages of
wound healing and is involved in platelet adhesion; A3, which binds to members of the laminin family;
A5, which associates with the beta 1 subunit to form a fibronectin receptor; A6, which associates with
beta 1 or 4 subunits and interacts with members of the laminin family; and ITGAV which regulates
angiogenesis. Integrin alpha 8 and integrin alpha L were both significantly up-regulated. The alpha 8
subunit regulates the recruitment of mesenchymal cells and mediates cell-cell interactions, while the
alpha L chain associates with the beta 2 sub-chain (which was approaching significant up-regulation
in this study) to form a receptor for lymphocytes. Members of the integrin beta subunits were also
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down-regulated: B1 and B3, both of which binds to alpha 5 subunit, which was also down-regulated.
The gene coding for the integrin beta 4 subunit was up-regulated. This subunit acts as a receptor for
the laminin family. In a study conducted by Giuliani and colleagues [67] the daily irradiation of mouse
embryonic fibroblasts for 3 days to a wavelength of 670 nm (pulsed wave, 0.21 mW/cm2, 4.3 mJ/cm2)
resulted in the up-regulation of ITGA5. This is in contract to our study, but may be due to the different
irradiation protocols.
Laminins are important in the formation and functioning of the basement membrane, and are
vital to cell adhesion, differentiation, migration and signalling. Forty-eight hours post-irradiation at
660 nm, diabetic wounded cells showed down-regulation in the genes coding for the alpha 1, beta 3
and gamma 1 subunits (LAMA1, LAMB3 and LAMC1, respectively). Genes coding for the alpha 3
(LAMA3) subunit was up-regulated. This gene is responsive to several growth factors, including
keratinocyte growth factor, epidermal growth factor (EGF) and insulin-like growth factor (IGF).
In a similar study, diabetic wounded fibroblast cells irradiated at the same parameters as in this
study (660 nm; 5 J/cm2) showed increased secretion of EGF, and subsequent activation of its receptor,
EGFR [57]. Giuliani and colleagues [67] found no effect on the gene regulation of LAMA1 when
they irradiated mouse embryonic fibroblasts (670 nm, 4.3 mJ/cm2). They also found no effect on
cadherin 1. In contrast, this study found a significant up-regulation in CDH1, which codes for cadherin
1. Cadherins are involved in cell–cell adhesion and promotes a distinctive cytoskeletal structure which
provides adhesive strength [68]. This study found a significant down-regulation in CTNND1, and
up-regulation in CTNND2. These genes code for adhesive junction proteins of the catenin family.
Catenin delta 2 protein is found to promote the disruption of E-cadherin adherens junctions which
favors the spreading of cells [54]. This study also found an up-regulation in the gene which codes
for contactin 1, CNTN1. This protein forms part of the immunoglobulin family, and functions as a
cell-adhesion molecule. The gene encoding for another immunoglobulin family member, VCAM1,
was also up-regulated. This gene codes for vascular cell adhesion molecule 1, and is a transmembrane
molecule. The gene for another transmembrane molecule, SELL, was also up-regulated. This gene
codes for selectin L. The KAL1 (or ANOS1) gene was down-regulated in cells 48 h post-irradiation
at 660 nm. The protein coded for by this gene, Kallmann syndrome 1 sequence, is believed to have
anti-protease activity [54].
5. Conclusions
Normal wound healing processes are disrupted and hindered in DM, and the management of
chronic diabetic ulcers remains a major global social and clinical challenge. Current therapies remain
inadequate, with repeated failure and relapse. Several papers have shown the beneficial effects of
PBM on diabetic wound healing, with favourable outcomes and no reported side-effects. This study
revealed that laser irradiation at a wavelength of 660 nm and a fluence of 5 J/cm2 had an effect on
a number of CAMs in a diabetic wounded fibroblast cell model. PBM influenced genes coding for
proteins related to transmembrane molecules, cell-cell adhesion, cell-matrix adhesion, and a number of
other CAMs. The difference seen in some of these studies may be due to different irradiation protocols
and time post-irradiation, which would affect phase of healing, as well as cell types and models used.
All of these need to be taken into consideration. Despite this, it cannot be denied that PBM has a
profound effect on the ECM and CAMs, leading to increased healing.
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